Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
Gotto GT, Yip SM, Shayegan B, O'Sullivan DE, Wallis CJD, Basappa NS, Cagiannos I, Hamilton RJ, Ferrario C, Fernandes R, Danielson B, Saad F, Hotte SJ, Cheung WY, Boyne DJ, Chan K, Osborne B, Zardan A, Malone S. Gotto GT, et al. Among authors: wallis cjd. Can Urol Assoc J. 2024 Aug 30. doi: 10.5489/cuaj.8691. Online ahead of print. Can Urol Assoc J. 2024. PMID: 39470659 Free article.
Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial.
Roy S, Sun Y, Morgan SC, Wallis CJD, King K, Zhou YM, D'souza LA, Azem O, Cueto-Marquez AE, Camden NB, Spratt DE, Kishan AU, Saad F, Malone S. Roy S, et al. Among authors: wallis cjd. Eur Urol. 2023 Jun;83(6):571-579. doi: 10.1016/j.eururo.2023.02.017. Epub 2023 Mar 7. Eur Urol. 2023. PMID: 36894488 Clinical Trial.
Effect of Pelvic External Beam Radiation Therapy on Bone Mineral Density: A Secondary Analysis of a Phase 3 Randomized Controlled Trial.
Roy S, Malone S, Sun Y, Zaorsky NG, Spratt DE, Morgan SC, Dess RT, Wallis CJD, Kishan AU, Citrin DE, Saad F. Roy S, et al. Among authors: wallis cjd. Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):119-126. doi: 10.1016/j.ijrobp.2023.10.046. Epub 2023 Nov 3. Int J Radiat Oncol Biol Phys. 2024. PMID: 37924987 Clinical Trial.
Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy A survey of specialized physicians.
Nguyen DD, Mousa A, Klotz L, Niazi T, Pouliot F, Kokorovic A, Lavallée LT, Huynh M, Lapointe N, Di Risio M, Wallis CJD. Nguyen DD, et al. Among authors: wallis cjd. Can Urol Assoc J. 2024 Jun;18(6):212-215. doi: 10.5489/cuaj.8687. Can Urol Assoc J. 2024. PMID: 38587979 Free PMC article. No abstract available.
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial.
Roy S, Sun Y, Chi KN, Ong M, Malone S, Wallis CJD, Kishan AU, Malone J, Swami U, Gebrael G, Brown JR, Jia AY, Morgan SC, Saad F, Chowdhury S, Agarwal N, Spratt DE. Roy S, et al. Among authors: wallis cjd. J Urol. 2024 Nov;212(5):672-681. doi: 10.1097/JU.0000000000004158. Epub 2024 Jul 26. J Urol. 2024. PMID: 39058790 Clinical Trial.
5-α Reductase Inhibitors and Prostate Cancer Mortality.
Hamilton RJ, Chavarriaga J, Khurram N, Lau C, Luo J, Liu N, Komisarenko M, Kulkarni G, Wallis C, Juurlink DN, Fleshner N, Finelli A. Hamilton RJ, et al. JAMA Netw Open. 2024 Aug 1;7(8):e2430223. doi: 10.1001/jamanetworkopen.2024.30223. JAMA Netw Open. 2024. PMID: 39190306 Free PMC article.
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial.
Roy S, Saad F, Sun Y, Malone S, Spratt DE, Kishan AU, Wallis CJD, Jia AY, Mohamad O, Swami U, Ong M, Agarwal N, Chowdhury S, Morgan SC. Roy S, et al. Among authors: wallis cjd. Eur J Cancer. 2024 Nov;211:114197. doi: 10.1016/j.ejca.2024.114197. Epub 2024 Jun 27. Eur J Cancer. 2024. PMID: 39243730 Clinical Trial.
288 results